Similarly, researchers in two studies found an association between Ki67 and clinicopathological parameters such as age, tumor size, hormone receptor status, and HER2 expression, reporting significant correlations between Ki67 and ER status and HER2 overexpression [29,30]. Here, MKI67 is linked to neoplasm.